CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Gordon Levine’s Immunotherapy Experience: A New Understanding of Advocacy

    Colorectal cancer veteran Gordon Levine discusses genomic testing, clinical trials, patient advocacy, and access to immunotherapy. 

    November 16, 2019| Sofia Balog
  • Ron

    Ron’s Immunotherapy Story

    Colorectal Cancer |  Diagnosed 2015 Immunotherapy definitely changed my life. Ron’s Story In 2015, Ron was diagnosed with…
    May 29, 2019| CRI Staff
  • Scientist Spotlight: Monica Olcina, DPhil

    Dr. Monica Olcina, a CRI-funded fellow at Stanford University, discusses her work on the complement system and…

    February 5, 2019| Arthur N. Brodsky, PhD
  • Recent FDA Announcements Herald Advances in Personalized Approaches Against Cancer

    Two tumor-profiling tests recently authorized by the FDA enable doctors to tailor their treatments more effectively to…

    December 22, 2017| Arthur N. Brodsky, PhD
  • Cindy Stowell Continues to Inspire

    Jeopardy! host Alex Trebek will make a special announcement on Tuesday, November 7th. 

    November 6, 2017| Alice Northover
  • CICON17 Day 3 Recap: Combinations, Checkpoint Immunotherapy Resistance, Immunomodulators, and Microbiota

    Day 3 of the CICON17 focused on combination therapies, immunomodulators, overcoming immune suppression, and the role bacteria in…

    September 9, 2017| Arthur N. Brodsky, PhD
  • Immunotherapy Makes History with Latest Cancer Approval

    The FDA’s biomarker-based approval of Keytruda was the first of its kind

    May 23, 2017| Arthur N. Brodsky, PhD
  • Stephen Estrada

    Stephen Estrada’s Immunotherapy Story

    Colorectal Cancer |  Diagnosed 2013 Most of all, I want the gift of immunotherapy to be accessible to…
    March 15, 2017| CRI Staff
  • Tom Marsilje

    Tom Marsilje’s Immunotherapy Story

    Colorectal Cancer |  Diagnosed June 4, 2012 In my 20 years of experience, I have never seen before…
    March 14, 2017| CRI Staff
Previous Page
1 2 3
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2026, Cancer Research Institute